OPTUS Pharmaceutical Co., Ltd. Logo

OPTUS Pharmaceutical Co., Ltd.

Develops and manufactures sterile, single-dose ophthalmic pharmaceutical products.

131030 | KO

Overview

Corporate Details

ISIN(s):
KR7131030009
LEI:
Country:
South Korea
Address:
충청북도 청주시 흥덕구 오송읍 오송생명6로 50, 청주시

Description

OPTUS Pharmaceutical Co., Ltd. is a specialized pharmaceutical company focused on the research, development, manufacturing, and commercialization of ophthalmic products. The company's primary expertise lies in producing sterile, preservative-free, single-dose (unit-dose) formulations. Its therapeutic portfolio addresses conditions such as dry eye syndrome, keratoconjunctival epithelial disease, bacterial conjunctivitis, and glaucoma. In addition to prescription and over-the-counter pharmaceuticals, the company is expanding into a total eye care model through its OUE& brand, which encompasses nutritional supplements (OUEFIT) and cosmeceuticals (OUELAB). The company operates EU-GMP certified manufacturing facilities and distributes its products globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 994.7 KB
2025-07-09 00:00
주식등의대량보유상황보고서(약식)
Korean 64.5 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 898.2 KB
2025-04-15 00:00
자기주식처분결과보고서
Korean 17.0 KB
2025-04-09 00:00
주요사항보고서(자기주식처분결정)
Korean 30.2 KB
2025-03-25 00:00
정기주주총회결과
Korean 33.7 KB
2025-03-25 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 18.4 KB
2025-03-25 00:00
대표이사변경
Korean 9.1 KB
2025-03-17 00:00
사업보고서 (2024.12)
Korean 1.1 MB
2025-03-13 00:00
감사보고서제출
Korean 17.6 KB
2025-03-10 00:00
[기재정정]주주총회소집공고
Korean 135.1 KB
2025-03-10 00:00
[기재정정]의결권대리행사권유참고서류
Korean 126.7 KB
2025-03-07 00:00
주주총회소집결의
Korean 19.1 KB
2025-03-07 00:00
주주총회소집공고
Korean 120.2 KB
2025-03-07 00:00
의결권대리행사권유참고서류
Korean 111.4 KB

Automate Your Workflow. Get a real-time feed of all OPTUS Pharmaceutical Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OPTUS Pharmaceutical Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OPTUS Pharmaceutical Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.